Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up

BACKGROUND: Treatment of autoimmune pulmonary alveolar proteinosis (aPAP) by inhaled granulocyte-macrophage colony stimulating factor (GM-CSF) is considered safe and effective. Evidence of benefit from GM-CSG inhalation for mild to moderate aPAP patients is limited. METHODS: In this multicenter, ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xinlun, Yang, Yanli, Chen, Lulu, Sui, Xin, Xu, Wenshuai, Li, Xue, Guo, Xiaobei, Liu, Lingshan, Situ, Yusen, Wang, Jun, Zhao, Yang, Meng, Shuzhen, Song, Wei, Xiao, Yonglong, Xu, Kai-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330972/
https://www.ncbi.nlm.nih.gov/pubmed/32615994
http://dx.doi.org/10.1186/s13023-020-01450-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330972/
https://www.ncbi.nlm.nih.gov/pubmed/32615994
http://dx.doi.org/10.1186/s13023-020-01450-4

Ejemplares similares